FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Another FDAer Charged in Illegal Scheme

[ Price : $8.95]

Just as the government has wrapped up an insider stock trading case involving a CDER chemist, another FDA employee comes under inv...

Attorney Reviews Possible Orange Book Changes

[ Price : $8.95]

Fish & Richardson managing principal Terry Mahn examines the Supreme Court's upcoming review of FDAs Orange Book and suggests need...

Transparency Blocked on Transparency Workshop

[ Price : $8.95]

Public interest group Judicial Watch releases emails from the White House showing how it orchestrated a block on reporters seeking...

FDA OKs Onfi for Certain Seizures

[ Price : $8.95]

FDA approves a Lundbeck NDA for Onfi tablets (clobazam) for use as an adjunctive treatment for seizures associated with Lennox-Gas...

FDA Studies Support Current Chantix Warnings

[ Price : $8.95]

FDA says that recent data from two studies show that Pfizer's smoking cessation drug Chantix (varenicline) is appropriately labele...

OMB OKs Info on Health and Diet Survey

[ Price : $8.95]

Federal Register Notice: The Office of Management and Budget approves an FDA collection of information, Health and Diet Survey.

Comments Sought on Registration of Drugs/Producers in Distribution

[ Price : $8.95]

Federal Register Notice: FDA seeks comments on a proposed collection of information on registration and listing of drug producers ...

Guidance on Frequent Blood Donor Questionnaires

[ Price : $8.95]

Federal Register Notice: FDA releases a draft guidance on implementing abbreviated donor history questionnaires to frequent blood ...

Oncologic Panel to Discuss 2 NDAs

[ Price : $8.95]

Federal Register Notice: FDAs Oncologic Drugs Advisory Committee will meet 12/7 to discuss Pfizers Inlyta for renal cell carcinoma...

FDA OKs Zyprexa/Zyprexa Zydus Generics

[ Price : $8.95]

FDA approves generic versions of Lillys Zyprexa and Zyprexa Zydus to treat schizophrenia and bipolar disorder from manufacturers D...